A grant from JDRF now unable DNA cloning of IC2. The project runs for two years and was initatied in September 2008.
News
IC2 cloning funded by Juvenile Diabetes Research Foundation
Welcome to ImmunoSigns
ImmunoSigns is a Biotech company founded in 1996. We offer you help in project management and R&D activities within biotechnology and immunodetection.
The core competance of ImmunoSigns is development and production of polyclonal and monoclonal antibodies and design and production of novel immunoassays and diagnostic kits, especially within the clinical area of diabetes and obesity.
© 2021 ImmunoSigns. All Rights Reserved.
Powered by WordPress. Designed by 